PJP vs. GERM
PJP (Invesco Dynamic Pharmaceuticals ETF) and GERM (Amplify Treatments, Testing and Advancements ETF) are both Health & Biotech Equities funds - PJP tracks the Dynamic Pharmaceuticals Intellidex Index while GERM tracks the Prime Treatments, Testing and Advancements Index. Both are passively managed. Over the past year, PJP returned 34.73% vs 0.00% for GERM. PJP charges 0.58%/yr vs 0.68%/yr for GERM.
Performance
PJP vs. GERM - Performance Comparison
Loading charts...
Returns By Period
PJP
- 1D
- 1.20%
- 1M
- 1.29%
- YTD
- 2.90%
- 6M
- 2.29%
- 1Y
- 34.73%
- 3Y*
- 13.31%
- 5Y*
- 7.62%
- 10Y*
- 6.15%
GERM
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- 0.00%
- 6M
- 0.00%
- 1Y
- 0.00%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
PJP vs. GERM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
PJP Invesco Dynamic Pharmaceuticals ETF | 2.90% | 27.98% | -3.47% |
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% | 0.00% |
PJP vs. GERM - Sectors Allocation Comparison
Sectors
PJP
GERM
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
PJP
GERM
Basic Materials
PJP
-
GERM
-
Communication Services
PJP
-
GERM
-
Consumer Cyclical
PJP
-
GERM
-
Consumer Defensive
PJP
-
GERM
-
Energy
PJP
-
GERM
-
Financial Services
PJP
-
GERM
Industrials
PJP
-
GERM
-
Real Estate
PJP
-
GERM
-
Technology
PJP
-
GERM
-
Utilities
PJP
-
GERM
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PJP vs. GERM — Risk / Return Rank
PJP
GERM
PJP vs. GERM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Dynamic Pharmaceuticals ETF (PJP) and Amplify Treatments, Testing and Advancements ETF (GERM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PJP | GERM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.36 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 3.70 | — | — |
| Martin ratioReturn relative to average drawdown | 11.55 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| PJP | GERM | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.13 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.47 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.34 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.59 | — | — |
Drawdowns
PJP vs. GERM - Drawdown Comparison
The maximum PJP drawdown since its inception was -37.06%, which is greater than GERM's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for PJP and GERM.
Loading charts...
Drawdown Indicators
| PJP | GERM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -37.06% | 0.00% | -37.06% |
Max Drawdown (1Y)Largest decline over 1 year | -9.44% | 0.00% | -9.44% |
Max Drawdown (3Y)Largest decline over 3 years | -16.27% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -17.51% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -33.95% | — | — |
Current DrawdownCurrent decline from peak | -2.94% | 0.00% | -2.94% |
Average DrawdownAverage peak-to-trough decline | -8.85% | 0.00% | -8.85% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.02% | 0.00% | +3.02% |
Volatility
PJP vs. GERM - Volatility Comparison
Invesco Dynamic Pharmaceuticals ETF (PJP) has a higher volatility of 5.33% compared to Amplify Treatments, Testing and Advancements ETF (GERM) at 0.00%. This indicates that PJP's price experiences larger fluctuations and is considered to be riskier than GERM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PJP | GERM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.33% | 0.00% | +5.33% |
Volatility (6M)Calculated over the trailing 6-month period | 12.02% | 0.00% | +12.02% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.38% | 0.00% | +16.38% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.17% | 0.00% | +16.17% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.39% | 0.00% | +18.39% |
PJP vs. GERM - Expense Ratio Comparison
PJP has a 0.58% expense ratio, which is lower than GERM's 0.68% expense ratio.
Dividends
PJP vs. GERM - Dividend Comparison
PJP's dividend yield for the trailing twelve months is around 0.99%, while GERM has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PJP Invesco Dynamic Pharmaceuticals ETF | 0.99% | 0.98% | 0.97% | 1.01% | 0.95% | 0.81% | 0.75% | 0.77% | 1.12% | 0.65% | 0.91% | 5.49% |
Frequently Asked Questions
PJP has higher volatility (5.33%) compared to GERM (0.00%). In terms of maximum drawdown, PJP dropped -37.06% vs GERM's 0.00%.
On 1-year performance, PJP leads with 34.73% vs 0.00% for GERM. On fees, PJP is cheaper at 0.58% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, PJP has performed better with a 34.73% return vs 0.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
PJP is cheaper with a 0.58% expense ratio, compared with 0.68% for GERM.
PJP has the higher dividend yield at 0.99%, compared with 0.00% for GERM.
PJP tracks Dynamic Pharmaceuticals Intellidex Index, while GERM tracks Prime Treatments, Testing and Advancements Index. They also come from different issuers: Invesco and Amplify. Their fees differ too: 0.58% for PJP and 0.68% for GERM.
Find the right allocation for PJP and GERM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer